Search research articles
Contact Us
Filters
Showing results (491-500 of 605) with videos related to
Page
of 61
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 25, 2024
Outcomes by <i>Candida</i> spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis
Jeffrey B Locke, Chris M Pillar, Mariana Castanheira, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 2, 2008
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease
J W Baddley, J R Perfect, R A Oster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2023
Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care Providers
Dallas J Smith, Rebecca J Free, George R Thompson, et al.
Frontiers in Immunology
|
December 21, 2020
The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice
Tingting Ge, Gaurang Jhala, Stacey Fynch, et al.
Journal of Clinical Microbiology
|
April 1, 1996
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group
M E Brandt, L C Hutwagner, L A Klug, et al.
The New England Journal of Medicine
|
June 15, 2007
Anidulafungin versus fluconazole for invasive candidiasis
Annette C Reboli, Coleman Rotstein, Peter G Pappas, et al.
Clinical Microbiology Reviews
|
July 13, 2023
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
George R Thompson, Jeffrey D Jenks, John W Baddley, et al.
The New England Journal of Medicine
|
November 17, 1994
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute
J H Rex, J E Bennett, A M Sugar, et al.
Antimicrobial Agents and Chemotherapy
|
June 15, 2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network
Shawn R Lockhart, Alicia J Zimbeck, John W Baddley, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 6, 2013
Recurrence after microwave ablation of liver malignancies: a single institution experience
Ryan T Groeschl, Ray K Wong, Edward J Quebbeman, et al.
Page
of 61
Search research articles
Search
Showing results (491-500 of 605) with videos related to
Sort By:
Page
of 61
Antimicrobial Agents and Chemotherapy
|
March 25, 2024
Outcomes by <i>Candida</i> spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis
Jeffrey B Locke, Chris M Pillar, Mariana Castanheira, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 2, 2008
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease
J W Baddley, J R Perfect, R A Oster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2023
Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care Providers
Dallas J Smith, Rebecca J Free, George R Thompson, et al.
Frontiers in Immunology
|
December 21, 2020
The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice
Tingting Ge, Gaurang Jhala, Stacey Fynch, et al.
Journal of Clinical Microbiology
|
April 1, 1996
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group
M E Brandt, L C Hutwagner, L A Klug, et al.
The New England Journal of Medicine
|
June 15, 2007
Anidulafungin versus fluconazole for invasive candidiasis
Annette C Reboli, Coleman Rotstein, Peter G Pappas, et al.
Clinical Microbiology Reviews
|
July 13, 2023
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
George R Thompson, Jeffrey D Jenks, John W Baddley, et al.
The New England Journal of Medicine
|
November 17, 1994
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute
J H Rex, J E Bennett, A M Sugar, et al.
Antimicrobial Agents and Chemotherapy
|
June 15, 2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network
Shawn R Lockhart, Alicia J Zimbeck, John W Baddley, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 6, 2013
Recurrence after microwave ablation of liver malignancies: a single institution experience
Ryan T Groeschl, Ray K Wong, Edward J Quebbeman, et al.
Page
of 61